APOE and Alzheimer disease: These endosomal abnormalities were more pronounced in patients with the ε4 allele and even more so in patients with late-onset FAD-APOE ε4 and Down Syndrome, who develop AD in aging due to Aβ production, as well as in patients with PS mutations causing early-onset (Cataldo et al., 1997).